UGX202 Injection in Patients With Advanced Retinitis Pigmentosa

NCT07311863 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Retinitis Pigmentosa (RP)

Interventions

GENETIC: UGX202 injection

Sponsor

Suzhou UgeneX Therapeutics Co., Ltd.

Collaborators

[object Object]